The project aims to find new methods for the development of drugs for schizophrenia and depression. The researchers will focus on developing new experimental models which use brain recording and behavioural tests to identify innovative and effective drugs for schizophrenia. They will develop standardised paradigms, acquisition and analysis techniques to apply brain imaging, especially fMRI and PET imaging to drug development. They will examine how variations in genes influence the response to various drugs and whether this information can be used to choose the right drug for the right patient. And finally, they will try and develop new approaches for shorter and more efficient trials of new medication.
 

NEWMEDS Publications